U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 155 results

Status:
US Approved Rx (2021)
First approved in 2021

Class (Stereo):
CHEMICAL (ABSOLUTE)



Maribavir (previously known as 1263W94) is a novel benzimidazole riboside compound. This drug was in phase III of clinical trial for the prevention of cytomegalovirus (CMV) infections in transplant patients, sponsored by ViroPharma. However, drug fai...
Status:
US Approved Rx (2009)
First approved in 2009

Class (Stereo):
CHEMICAL (EPIMERIC)



Pralatrexate (PDX or 10-propargyl-10-deazaaminopterin) is a folate analogue that is internalised by the reduced folate carrier 1 (RFC-1) protein, and polyglutamylated by the enzyme folylpolyglutamyl synthetase (FPGS), resulting in accumulation of the...
Status:
US Approved Rx (2013)
First approved in 2006

Class (Stereo):
CHEMICAL (ABSOLUTE)



Decitabine was first synthesized by Pliml and Sorm in the Institute of Organic Chemistry, Czechoslovak Academy of Sciences in 1964. Later, the drug was approved by FDA for the treatment of myelodysplastic syndromes in patients with cancer. Upon admin...
Status:
US Approved Rx (2022)
First approved in 2005

Class (Stereo):
CHEMICAL (ABSOLUTE)

Targets:


Arranon is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. It is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleoti...
Status:
US Approved Rx (2020)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Azacitidine (Vidaza; Pharmion), an inhibitor of DNA methylation, was approved by the US FDA for the treatment of myelodysplastic syndromes in May 2004. It is the first drug to be approved by the FDA for treating this rare family of bone-marrow disord...
Status:
US Approved Rx (2022)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pemetrexed is a new-generation antifolate, approved for the treatment of mesothelioma and non-small cell lung cancer, currently being evaluated for the treatment of a variety of other solid tumors. Pemetrexed, is a folate analog metabolic inhibitor ...
Status:
US Approved Rx (2023)
First approved in 2003

Class (Stereo):
CHEMICAL (ABSOLUTE)



Emtricitabine was discovered by Emory researchers Dr. Dennis C. Liotta, Dr. Raymond F. Schinazi and Dr. Woo-Baeg Choi and licensed to Triangle Pharmaceuticals by Emory University in 1996. Triangle was acquired by Gilead in 2003. Emtricitabine, market...
Status:
US Approved Rx (2011)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar® by Eli Lilly and Company. Gemcitabine inhibits thymidylate synthetase, leading to inhibition of DNA synthesis and cell death. Gemcitabine is a prodrug so activity occu...
Status:
US Approved Rx (1996)
First approved in 1994

Class (Stereo):
CHEMICAL (ACHIRAL)



Penciclovir (DENAVIR®) is a synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes simplex virus (HSV) types 1 and 2. In cells infected with HSV-1 or HSV-2, the viral thymidine kinase phosphorylates ...
Status:
US Approved Rx (2019)
First approved in 1993

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cladribine is used for the treatment of hairy cell leukemia and multiple sclerosis (MS). As a purine analog, it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, it mimics the nucleoside adenosine and thus inhibits ...